.
AFFiRiS is headquartered in Vienna, Austria.
AFFiRiS is a life science company.
AFFiRiS was founded in 2003.
Join Mergr to view all 0 acquisitions of life science companies in , including .
Karl-Farkas-Gasse 22,
Vienna,
1030
Austria,
+43 (1) 798 15 75 – 300
www.affiris.com
AFFiRiS is a clinical-stage biopharmaceutical company that pursues the ultimate aim to improve the lives of patients suffering from neurodegenerative diseases. AFFiRiS have a broad portfolio of immunotherapy candidates which are currently in clinical trials or in preclinical development for a variety of neurodegenerative diseases; these include Parkinson’s disease, multiple system atrophy (MSA), dementia with Lewy bodies (DLB), and Huntington’s disease (mutHTT). AFFiRiS was founded in 2003 and is based in Vienna, Austria.
| Year | ≤ '19 | '20 | '21 | '22 | '23 | '24 | T | |
|---|---|---|---|---|---|---|---|---|
| Buy (0.0/yr) | # | - | - | - | - | - | - | 0 |
| Sell (0.2/yr) | # | - | - | 1 | - | - | - | 1 |
| vol | $59M | $59M | ||||||
| 1 | ||||||||
| Company | Date | Value | Type |
|---|---|---|---|
| AFFiRiS - Specific Active Immunotherapy (SAIT) anti-alpha-synuclein Programs | 2021-07-27 | 59M USD | Divestiture |
| Vienna, Austria | |||
| View All >> | |||
| Sector | Buy # | Value | Sell # | Value | |
|---|---|---|---|---|---|
| Life Science | - | - | 1 (100%) | 59M (100%) | |
| Total | - | - | 1 | $59M | |
| State/Country | Buy | Value | Sell | Value | ||
|---|---|---|---|---|---|---|
| Austria | - | - | 1 | 59M | ||
| Total | - | - | 1 | $59M | ||
| sell | # | Total |
|---|---|---|
| < $100M | 1 | $59M |
| TOTAL | $59M | |
| Largest |
AFFiRiS - Specific Active Immunotherapy (SAIT) anti-alpha-synuclein Programs $59M (2021-07-27) |
|
| Deals | ||
|---|---|---|
| Divested to | ||
| Strategic(s) |
|
1 (100%) |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.
Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.
Try us for 1 week free today!
No obligation. Cancel anytime.
